Composition
- Active ingredients
- CILASTATIN SODIUM EQ 500MG BASE/VIAL; IMIPENEM 500MG/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CILASTATIN SODIUM EQ 250MG BASE/VIAL; IMIPENEM 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · PowderNDA050587-001 · Discontinued
- CILASTATIN SODIUM EQ 500MG BASE/VIAL; IMIPENEM 500MG/VIAL · PowderThis page
- CILASTATIN SODIUM EQ 250MG BASE/VIAL; IMIPENEM 250MG/VIAL · InjectableANDA062756-001 · Discontinued
- CILASTATIN SODIUM EQ 500MG BASE/VIAL; IMIPENEM 500MG/VIAL · InjectableANDA062756-002 · Discontinued
- CILASTATIN SODIUM EQ 500MG BASE/VIAL; IMIPENEM 500MG/VIAL · PowderNDA050630-001 · Discontinued
- CILASTATIN SODIUM EQ 750MG BASE/VIAL; IMIPENEM 750MG/VIAL · PowderNDA050630-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA050587.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Primaxin
- Active substance
- cilastatin sodium
- Route
- Intravenous
- Dosage form
- Powder
- Applicant
- Merck
- Status
- Prescription
- FDA approval
- 26 Nov 1985
- Application
- NDA050587-002